Cargando…
Tolerability and Reactogenicity Profile of mRNA SARS-Cov-2 Vaccines from a Mass Vaccination Campaign in a Tertiary Hospital: Between-Vaccine and Between-Population Prospective Observational Study (VigilVacCOVID Study)
BACKGROUND: The comparative safety profile of SARS-Cov2 vaccines requires further characterization in real-world settings. OBJECTIVES: The aim of the VigilVacCOVID study was to assess the short-term safety of BNT162b2 and mRNA-1273 during the vaccination campaign of healthcare professionals (HCPs) a...
Autores principales: | Sáez-Peñataro, Joaquín, Torres, Ferran, Bartra, Joan, Bascuas, Juan, Vilella, Anna, Tortajada, Marta, Quesada, Sebastiana, González, Elisenda, López-Suñé, Ester, Castells, Antoni, Serrano, Sandra, Camacho, Concepción, Trilla, Antoni, Calvo, Gonzalo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243773/ https://www.ncbi.nlm.nih.gov/pubmed/35764768 http://dx.doi.org/10.1007/s40259-022-00543-9 |
Ejemplares similares
-
Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
por: Cao, Yunlong, et al.
Publicado: (2021) -
The how’s and what’s of vaccine reactogenicity
por: Hervé, Caroline, et al.
Publicado: (2019) -
Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines
por: Zhang, Ruiqi, et al.
Publicado: (2022) -
Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
por: Cohen, Guy, et al.
Publicado: (2022) -
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines BNT162b2 and CoronaVac in healthy adolescents
por: Rosa Duque, Jaime S., et al.
Publicado: (2022)